EGFR-HER2 inhibitor AST-1306, Purity ≥98%

Cat. No.: X23-10-ZQ1052

EGFR-HER2 inhibitor AST-1306, Purity ≥98%

Synonym: AST-1306; Allitinib; 897383-62-9; AST1306; AST 1306; N-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)quinazolin-6-yl)acrylamide; EGFR-HER2 inhibitor

  • CAS Number: 897383-62-9
  • Compound CID: 24739943
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AST-1306 is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets EGFR, EGFR (L858R/T790M), ErbB2, and ErbB4.
Molecular Weight
448.9
Molecular Formula
C24H18ClFN4O2
Targets
EGFR: 0.5 nM; EGFR (L858R/T790M): 12 nM; ErbB2: 3 nM; ErbB4: 0.8 nM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
AST-1306 can be used as an irreversible inhibitor of EGFR for research into cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.